Inbar Nardi Agmon, Senior Cardiologist at Sheba Medical Center, shared on LinkedIn:
“Happy to share our recent webinar now available for watching: ‘Is cancer still a contraindication? Advanced cardiac procedures in oncology patients’
Thank you International Cardio-Oncology Society, Zaza Iakobishvili, Dan Gilon, Effie Andrikopoulou, for the invitation and collaboration!”
Watch the webinar.
About Inbar Nardi Agmon
Inbar Nardi Agmon is a senior cardiologist at Sheba Medical Center and heads its cardio-oncology service. Her work focuses on heart-related complications that can develop during cancer treatment. Alongside her clinical work, she is involved in research on treatment-related heart toxicity, the cardiovascular effects of immunotherapy and ways to better protect the heart health of cancer patients.
Her research mainly looks at how cancer treatments affect heart health, with a particular focus on:
- Immune checkpoint inhibitors: Studying how these drugs may affect the cardiovascular system and contribute to atherosclerosis.
- Cardiotoxicity: Looking into heart-related side effects of cancer treatments, including chemotherapy and immunotherapy.
- Cardiovascular risks in cancer patients: Finding ways to identify, prevent and manage heart complications during and after cancer treatment.
- Advanced cardiac procedures: Exploring the use and safety of different cardiac interventions in patients with cancer.
About the webinar
The webinar discusses the safety and feasibility of advanced cardiac procedures in patients with cancer. It explores how doctors can balance cardiovascular risks with cancer treatment needs, emphasizing that a cancer diagnosis should not automatically prevent patients from receiving necessary heart interventions. It also highlights the importance of collaboration between cardiologists and oncologists in making individualized treatment decisions.
The webinar features Inbar Nardi Agmon, Zaza Iakobishvili, Dan Gilon, Effie Andrikopoulou, and Joe Carver.
You may also be interested in: